---
figid: PMC5217037__oncotarget-07-48547-g007
figlink: /pmc/articles/PMC5217037/figure/F7/
number: F7
caption: In this map, NF-κB upregulates the transcription of miR-130b, which decreases
  CYLD expression and disrupts the negative feedback of CYLD on NF-κB activation.
  This axis leads to the constitutive activation of NF-κB signaling and promotes the
  progression of TCC.
pmcid: PMC5217037
papertitle: miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB
  and sustains NF-κB activation by decreasing Cylindromatosis expression.
reftext: Xiaolu Cui, et al. Oncotarget. 2016 Jul 26;7(30):48547-48561.
pmc_ranked_result_index: '12387'
pathway_score: 0.9427881
filename: oncotarget-07-48547-g007.jpg
figtitle: miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NFKB
  and sustains NFKB activation by decreasing Cylindromatosis expression
year: '2016'
organisms: Homo sapiens
ndex: 398ba353-df03-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5217037__oncotarget-07-48547-g007.html
  '@type': Dataset
  description: In this map, NF-κB upregulates the transcription of miR-130b, which
    decreases CYLD expression and disrupts the negative feedback of CYLD on NF-κB
    activation. This axis leads to the constitutive activation of NF-κB signaling
    and promotes the progression of TCC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRR1
  - REL
  - RELB
  - NFKB2
  - TRAF2
  - RELA
  - NFKB1
  - BIRC2
  - TNF
  - CHUK
  - IKBKB
  - IKBKG
  - TNFRSF1A
  - BIRC3
  - CYLD
genes:
- word: RIP1
  symbol: RIP-1
  source: hgnc_alias_symbol
  hgnc_symbol: KRR1
  entrez: '11103'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: c-IAP1
  symbol: c-IAP1
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC2
  entrez: '329'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: C-IAP2
  symbol: c-IAP2
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC3
  entrez: '330'
- word: CYLD
  symbol: CYLD
  source: hgnc_symbol
  hgnc_symbol: CYLD
  entrez: '1540'
chemicals: []
diseases: []
figid_alias: PMC5217037__F7
redirect_from: /figures/PMC5217037__F7
figtype: Figure
---
